meddevicedb.com FDA Device Reference

EASYRA CREATININE REAGENT

K123586 Class II Special
Decision Date
2013-05-15
Sponsor / Applicant
Medica Corporation

Technical Specification

510(k) Submission ID K123586
Product Code CGX
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1225
Decision Date 2013-05-15
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

EASYRA CREATININE REAGENT received FDA 510(k) clearance under submission number K123586, sponsored by Medica Corporation. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2013-05-15.

Classification & Regulation

This clearance is catalogued under FDA product code CGX and 21 CFR 862.1225, within the Clinical Chemistry review panel as a Class II device.